Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Evogene Ltd. Board/Management Information 2016

Dec 29, 2016

6785_rns_2016-12-29_dabb096c-b0a5-42b0-a51c-30497b8cbd2f.htm

Board/Management Information

Open in viewer

Opens in your device viewer

_________ false

����� ��"� 2 380
EVOGENE LTD
Corporation no: 512838723 10571
- - -
Israel Securities Authority Tel Aviv Stock Exchange C002 ( Public ) Reported via MAGNA: 29/12/2016
www.isa.gov.il www.tase.co.il Reference: 2016-02-145252 Time of broadcast: 17:02 16:48:54

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on Changes in management
Changes_in_management_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: -1 Date of revision of form structure: 28/12/2016
Address: Gad Feinstein St 13, P.O.B 2100 , Rehovot 76121   , Tel: 08-9311900 , Fax: 08-9466724
E-mail address: [email protected]   Company site: www.evogene.com
Previous names of reporting entity:
Name of the Signatory: Masliah Sassi Position of Signatory in the reporting corporation: Adv., Corporate Secretary Name of Employer Company:
Address: Eizenberg Aharon 19 , Rehovot 7629008 Telephone: 08-9311971 Facsimile: 08-9466724 E-mail: [email protected] 1